What is the Atlas of MS?
|Country of Interest:
|Barriers to accessing rehabilitation therapies||Barrier present in country of interest?||World Bank category High income||WHO region European||Global results|
|% of countries reporting reasons for rehabilitation therapies being rationed or not available quickly enough|
|Lack of awareness of therapies amongst healthcare professionals||data not known||36%||42%||52%|
|Lack of healthcare professionals able to provide therapies||data not known||56%||52%||59%|
|Equipment for therapies not readily available||data not known||14%||33%||38%|
|Too expensive for the government, health/insurance provider||data not known||56%||67%||57%|
|Too expensive for people with MS||data not known||47%||45%||55%|
|People with MS do not take the rehabilitation therapies offered||data not known||17%||12%||15%|
|Therapies are not available in all parts of the country||data not known||56%||58%||66%|
|Therapies are not available consistently over time||data not known||53%||45%||48%|
|Bureaucracy, inefficiency or complexity in health system||data not known||44%||39%||40%|
Professor of Neuro-Ophthalmology at Cairo University – Egypt.
Founder of MS Care and Chair of MSIF Board